Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1722 | 2517 | 24.4 | 66% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
657 | 3 | LANGERHANS CELL HISTIOCYTOSIS//AUTOIMMUNE PANCREATITIS//INFLAMMATORY PSEUDOTUMOR | 11219 |
2044 | 2 | LANGERHANS CELL HISTIOCYTOSIS//ROSAI DORFMAN DISEASE//HISTIOCYTOSIS | 5367 |
1722 | 1 | LANGERHANS CELL HISTIOCYTOSIS//EOSINOPHILIC GRANULOMA//HISTIOCYTOSIS X | 2517 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LANGERHANS CELL HISTIOCYTOSIS | authKW | 7682322 | 30% | 84% | 755 |
2 | EOSINOPHILIC GRANULOMA | authKW | 1785597 | 8% | 74% | 199 |
3 | HISTIOCYTOSIS X | authKW | 1583277 | 6% | 86% | 152 |
4 | HISTIOCYTOSIS | authKW | 637728 | 6% | 32% | 162 |
5 | LCH | authKW | 252697 | 1% | 83% | 25 |
6 | LANGERHANS CELL SARCOMA | authKW | 249521 | 1% | 86% | 24 |
7 | HISTIOCYTOSIS LANGERHANS CELL | authKW | 243146 | 1% | 95% | 21 |
8 | LANGERHANS CELL GRANULOMATOSIS | authKW | 232573 | 1% | 91% | 21 |
9 | LANGERHANS CELL HISTIOCYTOSIS LCH | authKW | 232573 | 1% | 91% | 21 |
10 | PULMONARY LANGERHANS CELL HISTIOCYTOSIS | authKW | 199607 | 1% | 69% | 24 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pediatrics | 11470 | 24% | 0% | 597 |
2 | Pathology | 4647 | 13% | 0% | 318 |
3 | Dermatology | 4432 | 10% | 0% | 264 |
4 | Hematology | 2968 | 11% | 0% | 280 |
5 | Oncology | 2339 | 17% | 0% | 438 |
6 | Radiology, Nuclear Medicine & Medical Imaging | 1317 | 10% | 0% | 251 |
7 | Orthopedics | 791 | 5% | 0% | 135 |
8 | Otorhinolaryngology | 693 | 4% | 0% | 98 |
9 | Dentistry, Oral Surgery & Medicine | 543 | 4% | 0% | 106 |
10 | Respiratory System | 532 | 4% | 0% | 110 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | REFERENCE HISTIOCYTOSE LANGERHANSIENNE | 74293 | 0% | 88% | 7 |
2 | REFERENCE HISTIOCYTOSES | 42447 | 0% | 50% | 7 |
3 | SO ALBERTA CHILDRENS CANC PROGRAM | 39289 | 0% | 36% | 9 |
4 | REFERENCE HISTIOCYTOSE | 36390 | 0% | 100% | 3 |
5 | UNITE HEMATO ONCOL PEDIAT | 36390 | 0% | 100% | 3 |
6 | SERV HEMATO ONCOL PEDIAT | 31041 | 0% | 32% | 8 |
7 | HEMATO ONCOL PEDIAT | 27291 | 0% | 75% | 3 |
8 | BIO CRUCES HLTH | 24260 | 0% | 100% | 2 |
9 | C S U1153 | 24260 | 0% | 100% | 2 |
10 | EQUIPE RECH BIOSTAT EPIDEMIOL CLIN | 24260 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MEDICAL AND PEDIATRIC ONCOLOGY | 22357 | 3% | 3% | 68 |
2 | PEDIATRIC BLOOD & CANCER | 13826 | 3% | 2% | 72 |
3 | JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 7639 | 2% | 1% | 48 |
4 | PEDIATRIC RADIOLOGY | 3435 | 2% | 1% | 44 |
5 | AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 2727 | 1% | 2% | 15 |
6 | PEDIATRIC HEMATOLOGY AND ONCOLOGY | 2354 | 1% | 1% | 20 |
7 | HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2142 | 1% | 1% | 19 |
8 | GASLINI | 2020 | 0% | 17% | 1 |
9 | SKELETAL RADIOLOGY | 1549 | 1% | 1% | 26 |
10 | PEDIATRIC DERMATOLOGY | 1412 | 1% | 1% | 21 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MARGO, CE , GOLDMAN, DR , (2008) LANGERHANS CELL HISTIOCYTOSIS.SURVEY OF OPHTHALMOLOGY. VOL. 53. ISSUE 4. P. 332 -358 | 130 | 76% | 17 |
2 | MATAIX, J , BETLLOCH, I , (2009) LANGERHANS CELL HISTIOCYTOSIS: AN UPDATE.GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA. VOL. 144. ISSUE 2. P. 119-134 | 89 | 95% | 5 |
3 | MORIMOTO, A , OH, Y , SHIODA, Y , KUDO, K , IMAMURA, T , (2014) RECENT ADVANCES IN LANGERHANS CELL HISTIOCYTOSIS.PEDIATRICS INTERNATIONAL. VOL. 56. ISSUE 4. P. 451 -461 | 79 | 90% | 4 |
4 | MINKOV, M , (2011) MULTISYSTEM LANGERHANS CELL HISTIOCYTOSIS IN CHILDREN CURRENT TREATMENT AND FUTURE DIRECTIONS.PEDIATRIC DRUGS. VOL. 13. ISSUE 2. P. 75 -86 | 68 | 94% | 36 |
5 | OBERT, J , TAZI, A , (2015) PULMONARY MANIFESTATIONS OF LANGERHANS CELL HISTIOCYTOSIS.REVUE DES MALADIES RESPIRATOIRES. VOL. 32. ISSUE 8. P. 850 -866 | 73 | 83% | 1 |
6 | MONSEREENUSORN, C , MINKOV, M , RODRIGUEZ-GALINDO, C , (2016) CURRENT TREATMENT OF LANGERHANS CELL HISTIOCYTOSIS.EXPERT OPINION ON ORPHAN DRUGS. VOL. 4. ISSUE 10. P. 1057 -1068 | 69 | 87% | 0 |
7 | ABLA, O , EGELER, RM , WEITZMAN, S , (2010) LANGERHANS CELL HISTIOCYTOSIS: CURRENT CONCEPTS AND TREATMENTS.CANCER TREATMENT REVIEWS. VOL. 36. ISSUE 4. P. 354-359 | 64 | 88% | 68 |
8 | ALLEN, CE , MCCLAIN, KL , (2007) LANGERHANS CELL HISTIOCYTOSIS: A REVIEW OF PAST, CURRENT AND FUTURE THERAPIES.DRUGS OF TODAY. VOL. 43. ISSUE 9. P. 627-643 | 87 | 76% | 25 |
9 | WANG, Y , QIU, B , LI, P , CHENG, P , LI, GY , LI, XG , XU, HT , WANG, YJ , (2012) MULTIFOCAL INTRAPARENCHYMAL LANGERHANS' CELL HISTIOCYTOSIS CONCOMITANT WITH AN ARACHNOID CYST IN A CHILD: CASE REPORT AND REVIEW OF THE LITERATURE.JOURNAL OF CHILD NEUROLOGY. VOL. 27. ISSUE 6. P. 767-778 | 66 | 90% | 1 |
10 | TAZI, A , (2006) ADULT PULMONARY LANGERHANS' CELL HISTIOCYTOSIS.EUROPEAN RESPIRATORY JOURNAL. VOL. 27. ISSUE 6. P. 1272-1285 | 90 | 67% | 78 |
Classes with closest relation at Level 1 |